Stock Track | Sotera Health Plummets 5.03% Intraday on Q4 Pretax Profit Miss and 2026 Guidance

Stock Track
02/25

Sotera Health Company's stock plummeted 5.03% during intraday trading on Tuesday, following the release of its fourth-quarter 2025 financial results and 2026 outlook.

The company reported a Q4 pretax profit of $70.5 million, which fell short of the IBES estimate of $96.4 million. This miss appears to be a primary driver behind the stock's decline. For the full year 2026, Sotera Health provided adjusted EPS guidance in the range of $0.93 to $1.01, which aligns closely with the FactSet consensus estimate of $0.94.

While the company delivered a revenue beat for Q4 and showed year-over-year growth, the significant shortfall in pretax profit compared to analyst expectations likely prompted a negative market reaction during the session.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10